ALN-PNP
ALN-PNP-NASH-2255
Phase 1 small_molecule completed
Quick answer
ALN-PNP for Nonalcoholic Fatty Liver Disease (NAFLD) is a Phase 1 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Nonalcoholic Fatty Liver Disease (NAFLD)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed